| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
59,923 |
55,303 |
$9.27M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
37,107 |
33,378 |
$26K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,194 |
7,426 |
$16K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
517 |
361 |
$13K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,325 |
2,177 |
$7K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
52 |
49 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
644 |
583 |
$631.92 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,111 |
3,514 |
$504.37 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
967 |
783 |
$274.53 |
| 98940 |
|
124 |
83 |
$183.92 |
| 81003 |
|
1,127 |
934 |
$153.14 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
591 |
529 |
$71.80 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
172 |
151 |
$28.19 |
| 90686 |
|
56 |
49 |
$15.22 |
| 81025 |
|
273 |
221 |
$0.00 |
| 2028F |
|
17 |
17 |
$0.00 |
| 99173 |
|
24 |
24 |
$0.00 |
| 86703 |
|
12 |
12 |
$0.00 |
| 11721 |
|
141 |
57 |
$0.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
18 |
18 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
138 |
109 |
$0.00 |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
125 |
123 |
$0.00 |
| 85018 |
|
13 |
12 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
57 |
44 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
129 |
102 |
$0.00 |
| 90656 |
|
97 |
84 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
13 |
13 |
$0.00 |
| 92250 |
|
17 |
17 |
$0.00 |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
25 |
25 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
37 |
30 |
$0.00 |
| 99000 |
|
25 |
25 |
$0.00 |